UCD team presenting COVend research results at the European Congress of Immunology 2024
UCD team presenting COVend research results at the European Congress of Immunology 2024 In September 2024, our partners, Zhiran Wang and Günther Eissner from University College Dublin’s Systems Biology Ireland, participated in the 7th European Congress of Immunology in Dublin. This event, hosted by the Irish Society for Immunology and the European Federation of Immunological […]
COVend featured in the Horizon Europe magazine article “Breathing easier – nature-inspired treatments could relieve acute respiratory distress”
COVend featured in the Horizon Europe magazine article “Breathing easier – nature-inspired treatments could relieve acute respiratory distress” We are thrilled to announce that COVend has been featured in a highly acclaimed Horizon magazine for our innovative and nature-inspired approach to treating acute respiratory distress syndrome (ARDS). The article, titled “Breathing easier – nature-inspired treatments […]
COVend research presented at 7th European Congress of Immunology in Dublin, 2 September 2024
COVend research presented at 7th European Congress of Immunology in Dublin, 2 September 2024 Our COVend project partner, Zhiran Wang, a researcher from University College Dublin, Systems Biology Ireland, will be participating in the 7th European Congress of Immunology in Dublin! The event, hosted by the Irish Society for Immunology and the European Federation of […]
COVend presented at Euroanaesthesia 2024 Congress in Munich, May 25-27
COVend presented at Euroanaesthesia 2024 Congress in Munich, May 25-27 On May 25-27, COVend participated in the Euroanaesthesia 2024 Congress in Munich, Germany, organised by our partner, the European Society of Anaesthesiology and Intensive Care (ESAIC). This was a significant moment for our project as we had the opportunity to showcase our progress and achievements […]
COVend partners at EMBL Conference, EMBO Workshop: Building Networks 2024 in Barcelona, Spain
COVend partners at EMBL Conference, EMBO Workshop: Building Networks 2024 in Barcelona, Spain The EMBL Conference, EMBO Workshop: Building Networks 2024 took place in Barcelona, Spain on May 6-8, bringing together researchers, scientists, and experts in the field of vascular biology. The event aimed to foster collaboration, share cutting-edge research, and advance our understanding of […]
Major Milestone Reached: COVend’s IXION 2.0 trial enrols its first patients!
We are excited to announce the start of patient enrollment for the IXION 2.0 clinical trial at the Goethe University Hospital Frankfurt. Due to the evolving dynamics of COVID-19, the project’s focus has shifted to investigating the potential benefits of the FX06 drug for patients with acute respiratory distress syndrome (ARDS). Spearheaded by Prof. Zacharowski and Dr. Petra Wülfroth, the co-founder of F4 Pharma in Vienna, the consortium and clinical trial were restructured in record time, underlining the unwavering joint commitment to innovative medical research in critical health conditions.
Groundbreaking research on Idiopathic Systemic Capillary Leak Syndrome: FX06 is Pioneering New Frontiers in Clarkson Disease Treatment
Our COVend consortium member F4 Pharma’s cooperation partners presented groundbreaking research on Idiopathic Systemic Capillary Leak Syndrome (ISCLS), also known as Clarkson disease, first at the 124° Congresso Nazionale of the Societa Italiana di Medicina Interna (SIMI) in October 2023. Now their paper is officially published in Biomedicine & Pharmacotherapy.
COVend presented at ISPOR Europe 2023
On the 13th of November, the consortium member of our partner institution UMCG, Clazinus Veijer, presented his poster “Lessons learned from model-based economic evaluations of COVID-19 treatments under pandemic circumstances: results from a systematic review ” at ISPOR Europe 2023. The poster highlighted results from a systematic review of various methodological characteristics of model-based economic evaluations of COVID-19 treatments.
COVend presented at the joint conference of the Société Française d’Immunologie and Deutsche Gesellschaft für Immunologie in Strasbourg
Exciting research from COVend presented at the joint conference of the Société Française d’Immunologie & Deutsche Gesellschaft für Immunologie in Strasbourg!
COVend Partners at University College Dublin Uncover Unique Cytokine Response in COVID-19
COVend Partners at University College Dublin Uncover Unique Cytokine Response in COVID-19 In the ongoing fight against COVID-19, COVend is dedicated to pushing the boundaries of scientific knowledge. Together with our partners at University College Dublin and Systems Biology Ireland, including Günther Eißner, Zhiran Wang, Vadim Zhernovkov, and Dmitrii Lebedev, we are delving into the […]
